Syn2bio Spolka Akcyjna (S2B)
GPW
Closed
Aug 21, 2026
Day's Range
60.0152 wk Range
26.20Overview - S2B - Syn2bio Spolka Akcyjna
Key Statistics
Valuation
Enterprise Value
536.37M
EV / EBITDA
‪-18.93‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-90.28%‬
Return on Equity
‪-141.88%‬
Ownership
Shares Outstanding
8.72M
Held by Insiders
‪39.79%‬
Held by Institutions
‪8.45%‬
Price stats
50-Day Avg
‪60.58‬
200-Day Avg
‪48.41‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - S2B - Syn2bio Spolka Akcyjna
Peers - S2B - Syn2bio Spolka Akcyjna
Peer Comparison
Compared with companies in Biotechnology listed on GPW.
- S2BGPWSyn2bio Spolka Akcyjna542.95MMarket Cap+42.60%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- BSTGPWBest S.A.974.02MMarket Cap+25.15%52-week change7.34P/E (Trailing)‪23.56%‬Profit Margin
- BCXGPWBioceltix S.A.442.58MMarket Cap-32.50%52-week change-26.67P/E (Trailing)‪0.00%‬Profit Margin
- BIOGPWBioton S.A.323.70MMarket Cap-11.14%52-week change75.40P/E (Trailing)‪1.52%‬Profit Margin
- APEGPWAps Energia S.A.156.71MMarket Cap+46.94%52-week change15.44P/E (Trailing)‪10.72%‬Profit Margin
- ASBPGPWAspire Biopharma Holdings Inc.7.83MMarket Cap-151.90%52-week change-0.01P/E (Trailing)‪-1.87%‬Profit Margin
- ASEPGPWAsep Medical Holdings Inc.1.44MMarket Cap-284.62%52-week change-0.10P/E (Trailing)‪-538.03%‬Profit Margin
Profile Summary - S2B - Syn2bio Spolka Akcyjna
About
Syn2bio Spolka Akcyjna is a biotechnology company focused on developing innovative radiopharmaceuticals and pharmaceutical molecules. It specializes in the research, development, and commercialization of advanced diagnostic agents, particularly a cardio marker—an innovative radiopharmaceutical designed for heart…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
